AI-assisted Software for Age-related Macular Degeneration (AMD)

Indication of Use

VeriSee AMD is indicated for the screening of AMD in adults aged 50 years and older, facilitating quick identification of high-risk cases without the need for an ophthalmologist.

Advantages

  • FDA Approval: First AI Software as a Medical Device (SaMD) for AMD approved by Taiwan FDA.
  • Autonomous Operation: Works with standard fundus cameras without requiring an internet connection.
  • Fast and Accurate: Delivers screening results within 10 seconds with 95% accuracy.
  • Clinical Validation: Proven performance in a pivotal trial, demonstrating 90% sensitivity and 96% specificity.
  • Ease of Use: Simplifies the AMD screening process, significantly reducing healthcare professional workload.
Categories , ,

Fill in the below to contact us

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia there live the blind texts.
Icon-facebook Twitter Instagram
×

Hello!

Click one of our contacts below to chat on WhatsApp

Social Chat is free, download and try it now here!

× Whatsapp Now!